Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval

Citi has flagged AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) accelerated approval for Etcamah, known chemically as camizestrant, as a meaningful sentiment...…

AstraZeneca: Share price weakness of late, should be capitalised on

Target changeChange in target pricep 14,380 vs 15,038 -4.38%We have tweaked our earnings estimates lower and considering the recent late-stage…

CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor

By Tom Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORTNew Findings Presented at European Society of Cardiology (ESC) Congress 2026On…

AZNs Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal

AstraZeneca reports positive SANOVO data, showing Tagrisso plus Orpathys improved PFS in first-line EGFR-mutated NSCLC.…

Top Stock Reports for AMD, Costco & AstraZeneca

AMD, Costco and AstraZeneca headline todays stock reports, with AI demand, membership growth and drug pipelines shaping their outlooks.…

Admission of Further Securities to Trading

1 September 2026Notification of Admission of Further Securities to Trading (PRM 1.6.4R)The following notification is made in accordance with The…

Total Voting Rights

1 September 2026Total Voting RightsThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure and Transparency…

AstraZeneca drug succeeds in trial for swallowing disorder

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) said its drug Tezspire worked in a late-stage trial of patients with eosinophilic esophagitis, a chronic…

AstraZeneca’s Tezspire meets trial goals for esophagitis

AstraZeneca’s Tezspire meets trial goals for esophagitis…

AstraZenecas asthma drug Tezspire meets all goals in late-stage esophagitis trial

AstraZeneca said on Thursday ?its asthma drug, Tezspire, developed with Amgen , ?met its main and secondary goals in a…

AstraZeneca prices €2.55bn euro bond sale across four tranches

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharma group, has priced a €2.55 billion bond offering, tapping the euro debt…

FTSE 100 Live: Miners lift London as oil and pharmaceutical stocks retreat

FTSE 100 rises 0.2% to 10,838 Mid-caps and AIM move slightly higher Mining, financial and industrial shares lead BP, AstraZeneca…

FTSE 100 Live: London opens flat as AstraZeneca offsets modest gains

FTSE 100 slips 0.06% to 10,810 Airtel Africa and Halma lead early risers AstraZeneca falls around 1% Gold holds near…

AstraZeneca Vs. Bristol-Myers Squibb: Whos The Better Bargain For Investors?

…

AstraZeneca maintains Citi buy rating despite mixed pipeline updates

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has retained a buy rating from Citi following a mixed set of pipeline updates, with the…

AstraZeneca maintains Citi buy rating despite mixed pipeline updates

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has retained a buy rating from Citi following a mixed set of pipeline updates, with the…

AstraZeneca: Pharmakonzern stoppt wichtige Studie zu Lungenkrebs-Mittel

Pharmariese AstraZeneca musste eine Studie für ein wichtiges Lungenkrebsmedikament stoppen. Es ist nicht der erste Fehlschlag in der jüngsten Zeit.…

AstraZeneca lung cancer drug combination extends survival in trial

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has reported positive results from a late-stage trial of a two-drug combination for a hard-to-treat form of…

AstraZeneca halts lung cancer trial in fresh pipeline setback

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has suffered its second pipeline setback in little over a month after halting a late-stage lung cancer…

FTSE 100 Live: Blue chips lose early lustre as mining rally runs out of steam

FTSE 100 up 4 at 10,755 Miners recover ground AZ resilient Posh house prices hit 10.55am: Drugmaker misses AstraZeneca shares proved…

LGND: XOMA Acquisition Closed

By John Vandermosten, CFANASDAQ: LGNDREAD THE FULL LGND RESEARCH NOTELigand Pharmaceuticals, Inc. (NASDAQ: LGND) reported second quarter 2026 results boasting…

AstraZeneca-BMY megadeal talk sparks huge market rift

Two of the worlds biggest drugmakers moved in opposite directions on Monday, and the split says a lot about how…

Brokers split on AstraZeneca merger talk as shares recover some ground

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) share price after…

AstraZeneca Investors See Little Logic in Bristol Tie-Up

AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don’t like the idea of a $400…

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?…

Analysts baffled by AstraZenecas interest in Bristol Myers Squibb

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts struggled…

Analysts baffled by AstraZenecas interest in Bristol Myers Squibb

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts struggled…

Stocks making the biggest moves premarket: Alibaba, AstraZeneca, eBay & more

These are the stocks posting the largest moves premarket.…

AstraZeneca slides after reports of Bristol Myers merger talks leave analysts perplexed

The companies have discussed a potential merger over several months, reports say.…

FTSE 100 held back by AstraZeneca as oil drops

The FTSE 100 started the week higher after Donald Trump said he planned to restart talks with Iran. The index rose in…

AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb

Shares in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) fell 7% to 11,723p on Monday after news that Britains biggest drugmaker is in talks…

AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb

Shares in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) fell 7% to 11,723p on Monday after news that Britains biggest drugmaker is in talks…

AstraZeneca shares slide 7% after reports of Bristol Myers talks

AstraZenecas shares fell sharply on Monday as analysts and investors questioned the logic of a possible tie-up with Bristol Myers…

FTSE 100 Live: Blue-chips to start August on front foot, AstraZeneca merger talks reported

7.47am: AstraZeneca in talks over $400 billion mega-merger AstraZeneca is in talks with Bristol Myers Squibb over a potential merger to…

FTSE 100 Live: London lagging as AstraZeneca tumbles, Shell sells renewables arm

FTSE 100 falls 1 point to 10,867 Housebuilders, airlines climb as oil and bonds fall AstraZeneca drops on reports of Bristol-Myers…

FTSE 100 Live: London lagging as AstraZeneca offsets gains from oil drop

9.14am: FTSE in the red The FTSE 100 is down 2 points at 10,866 after an hour and a bit of…

FTSE 100 Live: London lagging as AstraZeneca tumbles, US tech giants rally

FTSE 100 down 14 points to 10,854 Housebuilders, airlines climb as oil and bonds fall AstraZeneca drops on reports of…

FTSE 100 Live: Blue-chips start down as AstraZeneca and oil giants sink

8.15am: FTSE flat as AstraZeneca and oil giants slump The FTSE 100 has started in an uncertain manner, currently up…

FTSE 100 Live: London lagging as AstraZeneca plunges and commodities slip

FTSE 100 down 30 points to 10,838 Housebuilders, airlines climb as oil and bonds fall AstraZeneca drops on reports of…

AstraZenecas drug pipeine is splitting opinion among City analysts

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drug pipeline is splitting opinion among City brokers, with Citibank upgrading its price target to 17,800p...…

The Zacks Analyst Blog Highlights Apple, Microsoft, Amazon, LVMH, AstraZeneca, Shell, Airbus and UBS

AAPL, MSFT and AMZN earnings join key central bank meetings as investors track AI spending, interest rates and rising geopolitical…

AstraZeneca: Q2 2026 Results Were All Right, But Farxiga Poses Risks

…

Omeros gains as AstraZenecas Ultomiris fails in rare blood disorder

…

Astrazeneca (AZN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business performed in the quarter…

FTSE 100 gains as Vodafone and AstraZeneca impress

The FTSE 100 rose on Monday as traders reacted positively to a break in fighting in the Middle East, which…

AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares climbed to their highest in over two weeks after the drugmaker reported better second-quarter earnings than...…

AstraZeneca earnings beat forecasts despite slight revenue miss

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) reported better second-quarter earnings than expected as growth in oncology and rare diseases helped offset weaker...…

AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares climbed to their highest in over two weeks after the drugmaker reported better second-quarter earnings than...…

FTSE 100 Live: Stocks advance as oil price retreats, oil falls below $90

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…

FTSE 100 Live: Stocks advance as oil price retreats, retail downturn eases

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…